Equities research analysts at Wells Fargo & Co. (NYSE: WFC) started coverage on shares of Thermo Fisher Scient (NYSE: TMO) in a research note issued to investors on Thursday. The firm set a “market perform” rating on the stock.
Several other analysts have also recently commented on the stock. Analysts at Mizuho downgraded shares of Thermo Fisher Scient from a “buy” rating to a “neutral” rating in a research note to investors on Tuesday. They now have a $55.00 price target on the stock, down previously from $65.00. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Thermo Fisher Scient in a research note to investors on Friday, April 27th. They now have a $58.00 price target on the stock. Finally, analysts at UBS AG (NYSE: UBS) raised their price target on shares of Thermo Fisher Scient from $62.00 to $64.00 in a research note to investors on Thursday, April 26th. They now have a “buy” rating on the stock.
Shares of Thermo Fisher Scient traded down 0.66% during mid-day trading on Thursday, hitting $50.81. Thermo Fisher Scient has a one year low of $43.06 and a one year high of $65.86. The company has a market cap of $18.663 billion and a P/E ratio of 14.30.
Thermo Fisher Scient last issued its quarterly earnings data on Wednesday, April 25th. The company reported $1.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.06. The company’s revenue for the quarter was up 13.9% on a year-over-year basis. On average, analysts predict that Thermo Fisher Scient will post $1.19 earnings per share next quarter.
Thermo Fisher Scientific Inc. (Thermo Fisher) is engaged in serving science. It provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics.